Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

-Ahead of print
-Authors' Accepted
    Manuscripts
new!
-Current Issue
-Archive
-Acknowledgments
-Special Issues
-Browse by Category

Manuscript Submission

-Online Submission
-Online Review
-Instruction for Authors
-Instruction for Reviewers
-English Corner new!

About AJA

-About AJA
-Editorial Board
-Contact Us
-News

Resources & Services

-Advertisement
-Subscription
-Email alert
-Proceedings
-Reprints

Download area

-Copyright licence
-EndNote style file
-Manuscript word template
-Guidance for AJA figures
    preparation (in English)

-Guidance for AJA figures
    preparation (in Chinese)

-Proof-reading for the
    authors

-AJA Club (in English)
-AJA Club (in Chinese)

 
中文摘要

《亚洲男性学杂志》 2012; 14 (3): 405-408

《亚洲男性学杂志》 2012; 14 (3): 405–408

Cyr61,一个潜在的前列腺癌预后生物标记物

Naoki Terada, Prakash Kulkarni and Robert H Getzenberg (美国)

富半胱氨酸血管生成诱导因子61(Cyr61)是一种细胞外基质蛋白,与生长因子和激素的信号转导相关,且其表达量在几种癌症中会经常发生变化。Cyr61在器官局限性前列腺癌中呈高度表达。此外,Cyr61的表达水平与较低的疾病复发风险相关,且在血清中能够定量测定。综合考虑,上述结果表明Cyr61是一种潜在的,临床上实用的、基于组织和血清的生物标记物,可用于区分致死及非致死性前列腺癌。

关键词:Cyr61,致死性前列腺癌,非致死性前列腺癌,过度诊断,过度治疗,前列腺癌

此摘要文献来源:
Naoki Terada, Prakash Kulkarni and Robert H Getzenberg. Cyr61 is a potential prognostic marker for prostate cancer. Asian J Androl 2012; 14: 405–408.

 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.